Caisse Des Depots ET Consignations Acquires New Position in DaVita Inc. (NYSE:DVA)

Caisse Des Depots ET Consignations bought a new position in shares of DaVita Inc. (NYSE:DVA) during the fourth quarter, HoldingsChannel.com reports. The firm bought 11,250 shares of the company’s stock, valued at approximately $1,682,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DVA. Franklin Resources Inc. raised its stake in shares of DaVita by 134.6% in the third quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock valued at $8,885,000 after acquiring an additional 31,502 shares in the last quarter. FMR LLC raised its position in DaVita by 659.9% in the 3rd quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after purchasing an additional 154,061 shares in the last quarter. Atom Investors LP acquired a new position in shares of DaVita during the third quarter worth about $4,094,000. Assenagon Asset Management S.A. increased its stake in shares of DaVita by 201.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock worth $11,159,000 after buying an additional 49,885 shares during the period. Finally, Neo Ivy Capital Management acquired a new stake in DaVita in the third quarter valued at approximately $726,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Up 0.9 %

Shares of NYSE DVA opened at $152.73 on Friday. The firm has a 50-day moving average price of $157.71 and a 200 day moving average price of $157.50. DaVita Inc. has a 52 week low of $125.64 and a 52 week high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The stock has a market capitalization of $12.22 billion, a price-to-earnings ratio of 14.22, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Equities research analysts anticipate that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. Barclays increased their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 18th. Cowen reaffirmed a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. Finally, StockNews.com cut DaVita from a “buy” rating to a “hold” rating in a research note on Friday, March 21st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, DaVita presently has an average rating of “Hold” and an average target price of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.